Arca
Skip to content
Tools
Tools

Nitinol Staple, Elastic Staple Large-Asymmetrical

Recall Z-2262-2018, part of FDA recall event 80099. See TriMed's company page.

TriMed Inc. started this Class II device recall on Apr 13, 2018 (voluntary: firm initiated); FDA lists it as terminated, terminated Jan 22, 2021.

  • Classification: Class II
  • Started: Apr 13, 2018
  • Status: Terminated
  • Products in this event: 4

Why It Was Recalled

Class II

During a retrospective review of sterilization records, TriMed has determined that evidence of quarterly dose audits/verification required to comply with the regulations could not be found. Sterilization records indicate that all lots of staples were irradiated to at least the defined dose. There is a risk that this issue could result in patient infection if not properly sterilized.

Record

Product
Nitinol Staple, Elastic Staple Large-Asymmetrical, Sterile R, Model #: a) ES-18x15x17; b) ES-18x17x19
Quantity
532
Lots and codes
Lot #: a) R901, 03UU, 050522, 10505-22, 0344, 0051, 11805, 00AJ, 10505-23, 050523, 180502, 180901, 180503, 18902; b) 03UV, 050523, 10505-23, 00AJ, 0052, 180901, 11809, 180902, 26408, 264-08, 11805, 180502, 118901
Distribution
U.S.: IL, UT, PA, NJ, WA, TX, NV, CA, NC, MS, KS, MO, MN, FL; OUS: Australia and Sweden
Recalling firm
TriMed Inc., Santa Clarita, CA, United States
How the firm notified
Letter
FDA classified
Jun 20, 2018

Other Products in This Recall

Recall event 80099

TriMed Inc.'s Other Recalls

Newest first, one product per recall event; search them all

FDA's weekly Enforcement Report, as openFDA publishes it. A recall is classified by how likely the product is to cause harm: Class I is the most serious. openFDA device enforcement reports

Esc

Type a name: a tool, a company, a drug or brand, a condition, a gene or a state. Identifiers like K231234, NCT05012345 or NDA 215866 open their record.

Logos are each company's own site icon, matched by name through Wikidata, or logos provided by Logo.dev.Company names and logos identify the companies in public FDA and registry records and do not imply endorsement.